Novo Nordisk stock crashed Friday after the firm's next-generation weight-loss drug missed expectations in a highly ...

The Advanced Research Projects Agency for Health (ARPA-H) awarded TigaTx up to $33.5 million in funding. Tessera Therapeutics ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Y Intercept Hong Kong Ltd bought a new position in Allient Inc. (NASDAQ:ALNT – Free Report) in the third quarter, ...

BNP Paribas Financial Markets lifted its holdings in Kyverna Therapeutics, Inc. (NASDAQ:KYTX – Free Report) by 2,166.4% during the third quarter, according to the company in its most recent 13F filing ...

Novo Nordisk's controlling shareholder, Novo Holdings, has bought Catalent in a $16.5 billion deal that closed earlier Wednesday. At the time the deal was announced, Novo Nordisk (DK:NOVO.B), the ...

Novo Nordisk ( (NVO) ) has provided an announcement.

Novo Holdings A/S completed the acquisition of Catalent, Inc. (CTLT), a global contract development and manufacturing ...

Novo Holdings, the controlling shareholder of Novo Nordisk, on Wednesday sealed its $16.5 billion deal for Catalent, as the ...

Novo Holdings said that it completed it's $16.5 billion acquisition of Catalent Inc. (NYSE:CTLT). Shortly following the ...

Pain has really been out of favor in the industry up until very recently,” said John Mulcahy, SiteOne Therapeutics’ CEO. The ...